Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Clinical correlates of 9-hole peg test in a large population of people with multiple sclerosis.

Solaro C, Cattaneo D, Brichetto G, Castelli L, Tacchino A, Gervasoni E, Prosperini L.

Mult Scler Relat Disord. 2019 Jan 28;30:1-8. doi: 10.1016/j.msard.2019.01.043. [Epub ahead of print]

PMID:
30710887
2.
3.

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H.

J Neurol Neurosurg Psychiatry. 2019 Jan 13. pii: jnnp-2018-319831. doi: 10.1136/jnnp-2018-319831. [Epub ahead of print]

PMID:
30636699
4.

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study.

Nguyen AL, Havrdova EK, Horakova D, Izquierdo G, Kalincik T, van der Walt A, Terzi M, Alroughani R, Duquette P, Girard M, Prat A, Boz C, Sola P, Ferraro D, Lugaresi A, Lechner-Scott J, Barnett M, Grand'Maison F, Grammond P, Ramo-Tello C, Turkoglu R, McCombe P, Pucci E, Trojano M, Granella F, Spitaleri D, Van Pesch V, Soysal A, Oreja-Guevara C, Verheul F, Vucic S, Hodgkinson S, Slee M, Ampapa R, Prevost J, Menoyo JLS, Skibina O, Solaro C, Olascoaga J, Shaw C, Madsen KG, Naidoo K, Hyde R, Butzkueven H, Jokubaitis V; MSBase Study Group.

Mult Scler Relat Disord. 2019 Jan 3;28:235-243. doi: 10.1016/j.msard.2019.01.003. [Epub ahead of print]

PMID:
30623864
5.

Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.

Lorscheider J, Kuhle J, Izquierdo G, Lugaresi A, Havrdova E, Horakova D, Hupperts R, Duquette P, Girard M, Prat A, Grand'Maison F, Grammond P, Sola P, Ferraro D, Trojano M, Ramo-Tello C, Lechner-Scott J, Pucci E, Solaro C, Slee M, Van Pesch V, Sanchez Menoyo JL, van der Walt A, Butzkueven H, Kappos L, Kalincik T; MSBase Study Group.

Eur J Neurol. 2019 Feb;26(2):363-370. doi: 10.1111/ene.13824. Epub 2018 Nov 2.

PMID:
30298572
6.

e-Health and multiple sclerosis: An update.

Lavorgna L, Brigo F, Moccia M, Leocani L, Lanzillo R, Clerico M, Abbadessa G, Schmierer K, Solaro C, Prosperini L, Tedeschi G, Giovannoni G, Bonavita S.

Mult Scler. 2018 Nov;24(13):1657-1664. doi: 10.1177/1352458518799629. Epub 2018 Sep 19.

PMID:
30231004
7.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.

Kister I, Spelman T, Patti F, Duquette P, Trojano M, Izquierdo G, Lugaresi A, Grammond P, Sola P, Ferraro D, Grand'Maison F, Alroughani R, Terzi M, Boz C, Hupperts R, Lechner-Scott J, Kappos L, Pucci E, Hodgkinson S, Solaro C, Butzkueven H.

J Neurol Sci. 2018 Aug 15;391:72-76. doi: 10.1016/j.jns.2018.06.001. Epub 2018 Jun 2.

PMID:
30103975
8.

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.

Hughes J, Jokubaitis V, Lugaresi A, Hupperts R, Izquierdo G, Prat A, Girard M, Duquette P, Grand'Maison F, Grammond P, Sola P, Ferraro D, Ramo-Tello C, Trojano M, Slee M, Shaygannejad V, Boz C, Lechner-Scott J, Van Pesch V, Pucci E, Solaro C, Verheul F, Terzi M, Granella F, Spitaleri D, Alroughani R, Jun JK, Fambiatos A, Van der Walt A, Butzkueven H, Kalincik T; MSBase Study Group.

JAMA Neurol. 2018 Nov 1;75(11):1407-1415. doi: 10.1001/jamaneurol.2018.2109.

PMID:
30083762
9.

Refactory Trigeminal Neuralgia successfully treated by combination therapy (Pregabalin plus Lamotrigine).

Solaro CM, Ferriero G.

Mult Scler Relat Disord. 2018 Oct;25:165-166. doi: 10.1016/j.msard.2018.07.027. Epub 2018 Jul 27.

PMID:
30081317
10.

Direct Frequency-Comb-Driven Raman Transitions in the Terahertz Range.

Solaro C, Meyer S, Fisher K, DePalatis MV, Drewsen M.

Phys Rev Lett. 2018 Jun 22;120(25):253601. doi: 10.1103/PhysRevLett.120.253601.

PMID:
29979052
11.

Clinical measurement tools to assess trunk performance after stroke: a systematic review.

Sorrentino G, Sale P, Solaro C, Rabini A, Cerri CG, Ferriero G.

Eur J Phys Rehabil Med. 2018 Oct;54(5):772-784. doi: 10.23736/S1973-9087.18.05178-X. Epub 2018 Apr 20. Review.

12.

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.

Lanzillo R, Prosperini L, Gasperini C, Moccia M, Fantozzi R, Tortorella C, Nociti V, Annovazzi P, Cavalla P, Radaelli M, Malucchi S, Clerici VT, Boffa L, Buttari F, Ragonese P, Maniscalco GT, Di Filippo M, Buscarinu MC, Pinardi F, Gallo A, Coghe G, Pesci I, Laroni A, Gajofatto A, Calabrese M, Tomassini V, Cocco E, Solaro C; R.I.Re.MS study group.

J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.

PMID:
29549468
13.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
14.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
15.

Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.

Solaro C, Gamberini G, Masuccio FG.

CNS Drugs. 2018 Feb;32(2):117-133. doi: 10.1007/s40263-018-0489-5. Review.

PMID:
29417493
16.

Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria.

Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D'Amico E, Cruccu G, Truini A; Neuropathic Pain Special Interest Group of the Italian Neurological Society.

J Neurol. 2018 Apr;265(4):828-835. doi: 10.1007/s00415-018-8758-2. Epub 2018 Feb 5.

PMID:
29404736
17.

Evaluating upper limb impairments in multiple sclerosis by exposure to different mechanical environments.

Pellegrino L, Coscia M, Muller M, Solaro C, Casadio M.

Sci Rep. 2018 Feb 1;8(1):2110. doi: 10.1038/s41598-018-20343-y.

18.

Teriflunomide treatment reduces B cells in patients with MS.

Gandoglia I, Ivaldi F, Laroni A, Benvenuto F, Solaro C, Mancardi G, Kerlero de Rosbo N, Uccelli A.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e403. doi: 10.1212/NXI.0000000000000403. eCollection 2017 Nov.

19.

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

Kalincik T, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Lechner-Scott J, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Solaro C, Grand'Maison F, Hupperts R, Prevost J, Sola P, Ferraro D, Terzi M, Butler E, Slee M, Kermode A, Fabis-Pedrini M, McCombe P, Barnett M, Shaw C, Hodgkinson S, Butzkueven H; MSBase Study Group.

Mult Scler. 2018 Oct;24(12):1617-1626. doi: 10.1177/1352458517728812. Epub 2017 Aug 31.

PMID:
28857680
20.

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).

Messina S, Solaro C, Righini I, Bergamaschi R, Bonavita S, Bossio RB, Brescia Morra V, Costantino G, Cavalla P, Centonze D, Comi G, Cottone S, Danni MC, Francia A, Gajofatto A, Gasperini C, Zaffaroni M, Petrucci L, Signoriello E, Maniscalco GT, Spinicci G, Matta M, Mirabella M, Pedà G, Castelli L, Rovaris M, Sessa E, Spitaleri D, Paolicelli D, Granata A, Zappia M, Patti F; SA.FE. study group.

PLoS One. 2017 Aug 1;12(8):e0180651. doi: 10.1371/journal.pone.0180651. eCollection 2017.

21.

Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS.

Bommarito G, Bellini A, Pardini M, Solaro C, Roccatagliata L, Laroni A, Capello E, Mancardi GL, Uccelli A, Inglese M.

Mult Scler. 2018 Apr;24(5):623-631. doi: 10.1177/1352458517704077. Epub 2017 Apr 10.

PMID:
28394195
22.

A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

Ferraro D, Franciotta D, Bedin R, Solaro C, Cocco E, Santangelo M, Immovilli P, Gajofatto A, Calabrese M, Di Filippo M, Orlandi R, Simone AM, Vitetta F, Capello E, Giunti D, Murialdo A, Frau J, Mariotto S, Gallina A, Gasperini C, Sola P; RIREMS group (Rising Italian Researchers in Multiple Sclerosis).

J Neurol. 2017 May;264(5):973-978. doi: 10.1007/s00415-017-8480-5. Epub 2017 Apr 5.

PMID:
28382419
23.

Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres.

Mattarozzi K, Baldin E, Zenesini C, Solari A, Amato MP, Leone M, Mancardi G, Martinelli V, Savettieri G, Solaro C, Tola MR, D'Alessandro R; Agorà Study Group.

Eur J Neurol. 2017 Apr;24(4):631-637. doi: 10.1111/ene.13263. Epub 2017 Feb 21.

PMID:
28220581
24.

Country breakout session highlights.

Ghezzi A, Filli L, Solaro C, Mekies C, Landete L, Lycke J.

Neurodegener Dis Manag. 2016 Dec;6(6s):41-44.

PMID:
27874497
25.

Competition between Spin Echo and Spin Self-Rephasing in a Trapped Atom Interferometer.

Solaro C, Bonnin A, Combes F, Lopez M, Alauze X, Fuchs JN, Piéchon F, Pereira Dos Santos F.

Phys Rev Lett. 2016 Oct 14;117(16):163003. Epub 2016 Oct 14.

PMID:
27792384
26.

Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.

Solaro C, Trabucco E, Signori A, Martinelli V, Radaelli M, Centonze D, Rossi S, Grasso MG, Clemenzi A, Bonavita S, D'Ambrosio A, Patti F, D'Amico E, Cruccu G, Truini A.

PLoS One. 2016 Sep 15;11(9):e0160261. doi: 10.1371/journal.pone.0160261. eCollection 2016.

27.

Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Paolucci S, Martinuzzi A, Scivoletto G, Smania N, Solaro C, Aprile I, Armando M, Bergamaschi R, Berra E, Berto G, Carraro E, Cella M, Gandolfi M, Masciullo M, Molinari M, Pagliano E, Pecchioli C, Roncari L, Torre M, Trabucco E, Vallies G, Zerbinati P, Tamburin S; Italian Consensus Conference on Pain in Neurorehabilitation (ICCPN).

Eur J Phys Rehabil Med. 2016 Dec;52(6):827-840. Epub 2016 Aug 31.

28.

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.

Patti F, Messina S, Solaro C, Amato MP, Bergamaschi R, Bonavita S, Bruno Bossio R, Brescia Morra V, Costantino GF, Cavalla P, Centonze D, Comi G, Cottone S, Danni M, Francia A, Gajofatto A, Gasperini C, Ghezzi A, Iudice A, Lus G, Maniscalco GT, Marrosu MG, Matta M, Mirabella M, Montanari E, Pozzilli C, Rovaris M, Sessa E, Spitaleri D, Trojano M, Valentino P, Zappia M; SA.FE. study group.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):944-51. doi: 10.1136/jnnp-2015-312591. Epub 2016 May 9.

29.

Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy.

Loraschi A, Bellantonio P, Bortolon F, Capra R, Cavalla P, Costantino G, Lugaresi A, Martinelli V, Marrosu MG, Patti F, Rottoli M, Salvetti M, Sola P, Solaro C, Klersy C, Marino F, Zaffaroni M, Cosentino M.

Neurol Sci. 2016 Apr;37(4):613-22. doi: 10.1007/s10072-016-2519-8. Epub 2016 Feb 19.

PMID:
26895323
30.

Dalfampridine is associated with de novo occurrence or reoccurrence of positive sensory symptoms in MS.

Solaro C, Trabucco E, Messmer Uccelli M.

eNeurologicalSci. 2015 Nov 19;2:1-2. doi: 10.1016/j.ensci.2015.11.003. eCollection 2016 Mar. No abstract available.

31.

New hosts for the mite Ornithonyssus bursa in Argentina.

Santillán MÁ, Grande JM, Liébana MS, Martínez P, Díaz LA, Bragagnolo LA, Solaro C, Galmes MA, Sarasola JH.

Med Vet Entomol. 2015 Dec;29(4):439-43. doi: 10.1111/mve.12129. Epub 2015 Aug 10.

PMID:
26258483
32.

Italian validation of the 12-item multiple sclerosis walking scale.

Solaro C, Trabucco E, Signori A, Cella M, Messmer Uccelli M, Brichetto G, Cavalla P, Gironi M, Patti F, Prosperini L.

Mult Scler Int. 2015;2015:540828. doi: 10.1155/2015/540828. Epub 2015 Mar 26.

33.

Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.

Prosperini L, Annovazzi P, Capobianco M, Capra R, Buttari F, Gasperini C, Galgani S, Solaro C, Centonze D, Bertolotto A, Pozzilli C, Ghezzi A.

Mult Scler. 2015 Nov;21(13):1713-22. doi: 10.1177/1352458515570768. Epub 2015 Feb 19.

PMID:
25698174
34.

The changing face of multiple sclerosis: Prevalence and incidence in an aging population.

Solaro C, Ponzio M, Moran E, Tanganelli P, Pizio R, Ribizzi G, Venturi S, Mancardi GL, Battaglia MA.

Mult Scler. 2015 Sep;21(10):1244-50. doi: 10.1177/1352458514561904. Epub 2015 Jan 12.

PMID:
25583850
35.

Effect of radial shock wave therapy on pain and muscle hypertonia: a double-blind study in patients with multiple sclerosis.

Marinelli L, Mori L, Solaro C, Uccelli A, Pelosin E, Currà A, Molfetta L, Abbruzzese G, Trompetto C.

Mult Scler. 2015 Apr;21(5):622-9. doi: 10.1177/1352458514549566. Epub 2014 Sep 25.

PMID:
25257616
36.

Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality.

Di Battista G, Bertolotto A, Gasperini C, Ghezzi A, Maimone D, Solaro C.

Mult Scler Int. 2014;2014:752318. doi: 10.1155/2014/752318. Epub 2014 Aug 26.

37.

Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.

Laroni A, Gandoglia I, Solaro C, Ribizzi G, Tassinari T, Pizzorno M, Parodi S, Baldassarre G, Rilla MT, Venturi S, Capello E, Sormani MP, Uccelli A, Mancardi GL.

BMC Neurol. 2014 May 12;14:103. doi: 10.1186/1471-2377-14-103.

38.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

39.

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.

Frisullo G, Calabrese M, Tortorella C, Paolicelli D, Ragonese P, Annovazzi P, Radaelli M, Malucchi S, Gallo A, Tomassini V, Nociti V, D'Onghia M, Lo Re V, Rodegher M, Solaro C, Gasperini C.

Mult Scler. 2014 Aug;20(9):1265-8. doi: 10.1177/1352458514521311. Epub 2014 Feb 10.

PMID:
24515732
40.

The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.

Capra R, Battaglia MA, Gaudioso A, Lopes L, Paolicelli D, Paoloni M, Pozzilli C, Santilli V, Solaro C, Trojano M.

J Neurol. 2014 Mar;261(3):526-32. doi: 10.1007/s00415-013-7230-6. Epub 2014 Jan 22.

PMID:
24449060
41.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.

PMID:
24403285
42.

Growth hormone and disease severity in early stage of multiple sclerosis.

Gironi M, Solaro C, Meazza C, Vaghi M, Montagna L, Rovaris M, Batocchi AP, Nemni R, Albertini R, Zaffaroni M, Bozzola M.

Mult Scler Int. 2013;2013:836486. doi: 10.1155/2013/836486. Epub 2013 Oct 23.

43.

Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study.

Solaro C, Bergamaschi R, Rezzani C, Mueller M, Trabucco E, Bargiggia V, Dematteis F, Mattioda A, Cimino V, Restivo D, Patti F, Cavalla P.

Clin Neuropharmacol. 2013 Jul-Aug;36(4):114-6. doi: 10.1097/WNF.0b013e3182996400.

PMID:
23783007
44.

Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire).

Solaro C, Rezzani C, Trabucco E, Amato MP, Zipoli V, Portaccio E, Giannini M, Patti F, D'Amico E, Frau J, Lorefice L, Bonavita S, Della Corte M, Grasso MG, Finamore L, Ghezzi A, Annovazzi P, Rottoli M, Gasperini C, Restivo D, Maimone D, Rossi P, Stromillo ML, Bergamaschi R.

J Neurol Sci. 2013 Aug 15;331(1-2):94-7. doi: 10.1016/j.jns.2013.05.020. Epub 2013 Jun 6.

PMID:
23747002
45.

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

Pastò L, Portaccio E, Ghezzi A, Hakiki B, Giannini M, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi GL, Solaro C, Totaro R, Tola MR, Di Tommaso V, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2012 Dec 31;12:165. doi: 10.1186/1471-2377-12-165.

46.

Parkinsonism in multiple sclerosis patients: a casual or causal association?

Pedemonte E, Trabucco E, Cella M, Solaro C.

Parkinsonism Relat Disord. 2013 Apr;19(4):492-3. doi: 10.1016/j.parkreldis.2012.11.021. Epub 2012 Dec 23. No abstract available.

PMID:
23266513
47.

Pain and multiple sclerosis: pathophysiology and treatment.

Solaro C, Trabucco E, Messmer Uccelli M.

Curr Neurol Neurosci Rep. 2013 Jan;13(1):320. doi: 10.1007/s11910-012-0320-5. Review.

PMID:
23250765
48.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP.

BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124.

49.

Permanent genetic resources added to Molecular Ecology Resources Database 1 February 2012 - 31 March 2012.

Molecular Ecology Resources Primer Development Consortium, Andris M, Arias MC, Barthel BL, Bluhm BH, Bried J, Canal D, Chen XM, Cheng P, Chiappero MB, Coelho MM, Collins AB, Dash M, Davis MC, Duarte M, Dubois MP, Françoso E, Galmes MA, Gopal K, Jarne P, Kalbe M, Karczmarski L, Kim H, Martella MB, McBride RS, Negri V, Negro JJ, Newell AD, Piedade AF, Puchulutegui C, Raggi L, Samonte IE, Sarasola JH, See DR, Seyoum S, Silva MC, Solaro C, Tolley KA, Tringali MD, Vasemägi A, Xu LS, Zanón-Martínez JI.

Mol Ecol Resour. 2012 Jul;12(4):779-81. doi: 10.1111/j.1755-0998.2012.03155.x. Epub 2012 May 30.

PMID:
22642264
50.

Fatal pulmonary embolism: when the cause is not a thrombus.

Franco E, Frea S, Solaro C, Conti V, Pinneri F.

Spine (Phila Pa 1976). 2012 Mar 15;37(6):E411-3. doi: 10.1097/BRS.0b013e318230db1b.

PMID:
22422441

Supplemental Content

Loading ...
Support Center